Esophageal thermal injury by hot adlay tea

Reversible thermal injury to the esophagus as the result of drinking hot liquids has been reported to generate alternating white and red linear mucosal bands, somewhat reminiscent of a candy cane. This phenomenon is associated with chest pain, dysphagia, odynophagia, and epigastric pain. Here, we re...

Full description

Saved in:
Bibliographic Details
Published inThe Korean journal of internal medicine Vol. 22; no. 1; pp. 59 - 62
Main Authors Go, Hoon, Yang, Hyeon Woong, Jung, Sung Hee, Park, Young A, Lee, Jung Yun, Kim, Sae Hee, Lim, Sin Hyung
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Association of Internal Medicine 01.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Reversible thermal injury to the esophagus as the result of drinking hot liquids has been reported to generate alternating white and red linear mucosal bands, somewhat reminiscent of a candy cane. This phenomenon is associated with chest pain, dysphagia, odynophagia, and epigastric pain. Here, we report a case of thermal injury to the esophageal and oral cavity due to the drinking of hot tea, including odynophagia and dysphagia. A 69-year-old man was referred due to a difficulty in swallowing which had begun a week prior to referral. The patient, at the time of admission, was unable to swallow even liquids. He had recently suffered from hiccups, and had consumed five cups of hot adlay tea one week prior to admission, as a folk remedy for the hiccups. Upon physical examination, the patient's oral cavity evidenced mucosal erosion, hyperemia, and mucosa covered by a whitish pseudomembrane. Nonspecific findings were detected on the laboratory and radiological exams. Upper endoscopy revealed diffuse hyperemia, and erosions with thick and whitish pseudomembraneous mucosa on the entire esophagus. The stomach and duodenum appeared normal. We diagnosed the patient with thermal esophageal injury inflicted by the hot tea. He was treated with pantoprazole, 40 mg/day, for 14 days, and evidenced significant clinical and endoscopic improvement.
ISSN:1226-3303
2005-6648
DOI:10.3904/kjim.2007.22.1.59